C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/48 (2006.01) A61K 31/4168 (2006.01) A61K 31/4178 (2006.01) A61K 31/421 (2006.01) A61K 31/4439 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) C07D 233/88 (2006.01) C07D 239/46 (2006.01) C07D 249/14 (2006.01) C07D 263/48 (2006.01) C07D 401/12 (2006.01) C07D 409/04 (2006.01) C07D 413/10 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2532505
Compounds of formulae: (I), (II), (IIIa), (IIIb), (IVa) and (IVb): or a pharmaceutically acceptable salt thereof, for use as pharmaceuticals, in particular for the treatment of a condition alleviated by antagonism of a 5- HT2B receptor.
La présente invention concerne des composés de formules (I), (II), (IIIa), (IIIb), (IVa) et (IVb), ou des sels de ceux-ci, acceptables d'un point de vue pharmaceutique. Ces composés sont utilisés comme agents pharmaceutiques en particulier pour traiter un état pathologique atténué par l'antagonisme d'un récepteur 5-HT¿2B?.
Aley Amanda
Archer Janet Ann
Borman Richard Anthony
Clark Kenneth Lyle
Coleman Robert Alexander
Asterand Uk Limited
Kirby Eades Gale Baker
Pharmagene Laboratories Limited
LandOfFree
5-ht2b receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-ht2b receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-ht2b receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1554395